ClinVar Miner

Submissions for variant NM_174934.4(SCN4B):c.18C>A (p.Asp6Glu)

gnomAD frequency: 0.00019  dbSNP: rs149979176
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001698986 SCV000223636 uncertain significance not provided 2023-11-27 criteria provided, single submitter clinical testing Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868)
Ambry Genetics RCV000619472 SCV000735544 likely benign Cardiovascular phenotype 2024-08-05 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Labcorp Genetics (formerly Invitae), Labcorp RCV001216410 SCV001388207 uncertain significance Long QT syndrome 10 2025-02-02 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 6 of the SCN4B protein (p.Asp6Glu). This variant is present in population databases (rs149979176, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SCN4B-related conditions. ClinVar contains an entry for this variant (Variation ID: 190889). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago RCV001216410 SCV003920436 uncertain significance Long QT syndrome 10 criteria provided, single submitter clinical testing SCN4B NM_174934.3 exon 1 p.Asp6Glu (c.18C>A): This variant has not been reported in the literature but is present in 0.02% (30/124990) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-118023371-G-T). This variant is present in ClinVar (Variation ID:190889). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV005406881 SCV006072337 likely benign not specified 2025-03-07 criteria provided, single submitter clinical testing
Clinical Genetics, Academic Medical Center RCV001698986 SCV001922696 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV001698986 SCV001927453 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.